Skip to main content

Advertisement

SpringerLink
Log in

Elevated microRNA-185 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in clear cell renal cell carcinoma

  • Research Article
  • Published:
Tumor Biology

Abstract

MicroRNAs (miRNAs) are involved in a number of biological processes, including tumor biology. Previous studies have demonstrated that miRNA-185 regulates signaling downstream of vascular endothelial growth factor receptor 2 (VEGFR-2) and, consequently, angiogenesis. The aim of this study was to analyze the potential relationship between miRNA-185, VEGFR-2, and angiogenesis in samples from renal cell carcinoma (RCC) patients. Tumor tissue was obtained from 82 patients. The miRNA-185 and VEGFR-2 gene expression levels were analyzed by PCR, and the protein concentrations of VEGFR-2 were detected by ELISA. Angiogenesis, visualized by the endothelial cell marker CD34 combined with caldesmon, was assessed by immunohistochemistry and the microvessel density (MVD) technique. In situ hybridization was performed for miRNA-185. Tumors were classified as low or high miRNA-185-expressing using the median as the cutoff. The median gene expression levels of VEGFR-2 were significantly lower in the tumors expressing low levels of miRNA-185, 0.31 (95 % CI, 0.25–0.37), compared to those expressing high levels of miRNA-185, 0.47 (95 % CI, 0.27–0.59), p = 0.02. A positive association was certified with VEGFR-2 protein levels, p = 0.06. The median MVD was significantly lower in the tumors expressing low levels of miRNA-185, 6.8 (95 % CI, 6.33–7.67), compared to those expressing high levels, 8.0 (95 % CI, 6.33-9.00), p < 0.01. miRNA-185 was detected in endothelial cells by in situ hybridization detection. The results suggest that high levels of miRNA-185 in RCC are associated with high VEGFR-2 mRNA and protein levels and a higher density of microvessels. However, further investigation should be performed to analyze the prognostic value of miRNA-185 in RCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Miyamoto H, Miller JS, Fajardo DA, Lee TK, Netto GJ, Epstein JI, et al. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system. Pathol Int. 2010;60:1–8.

    Article  Google Scholar 

  2. Montironi R, Santinelli A, Pomante R, Mazzucchelli R, Colanzi P, Filho AL, et al. Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. Virchows Arch. 2000;437(1):82–9.

    Article  CAS  Google Scholar 

  3. Eklund L, Bry M, Alitalo K. Mouse models for studying angiogenesis and lymph-angiogenesis in cancer. Mol Oncol. 2013;7(2):259–82.

    Article  CAS  Google Scholar 

  4. Chekhonin VP, Shein SA, Korchagina AA, Gurina OI. VEGF in neoplastic angiogenesis. Vestn Ross Akad Med Nauk. 2012;2:23–33.

    Article  Google Scholar 

  5. Goel S, Wong AH, Jain RK. Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease. Cold Spring Harb Perspect Med. 2012;2(3):a006486.

    Article  Google Scholar 

  6. Adams BD, Kasinski AL, Slack FJ. Aberrant regulation and function of microRNAs in cancer. Curr Biol. 2014;24(16):R762–R77.

    Article  CAS  Google Scholar 

  7. Suzuki H, Maruyama R, Yamamoto E, Kai M. Epigenetic alteration and microRNA dysregulation in cancer. Front Genet. 2013;4:258.

    Article  Google Scholar 

  8. Hoffman AM, Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics. 2011;3(1):19–34.

    Article  CAS  Google Scholar 

  9. Li W, Liu M, Feng Y, Xu YF, Huang YF, Che JP, et al. Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1). Br J Cancer. 2014. doi:https://doi.org/10.1038/bjc.2014.382.

    Article  PubMed  PubMed Central  Google Scholar 

  10. McCormick RI, Blick C, Ragoussis J, Schoedel J, Mole DR, Young AC, et al. miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis. Br J Cancer. 2013;108(5):1133–42.

    Article  CAS  Google Scholar 

  11. Zhang Z, Tang H, Wang Z, Zhang B, Liu W, Lu H, et al. MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma. Mol Cancer. 2011;10:124.

    Article  CAS  Google Scholar 

  12. Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett. 2009;285(2):116–26.

    Article  CAS  Google Scholar 

  13. Cheng CJ, Slack FJ. The duality of oncomiR addiction in the maintenance and treatment of cancer. Cancer J. 2012;18(3):232–7.

    Article  Google Scholar 

  14. Ho JJ, Metcalf JL, Yan MS, Turgeon PJ, Wang JJ, Chalsev M, et al. Functional importance of Dicer protein in the adaptive cellular response to hypoxia. J Biol Chem. 2012;287(34):29003–20.

    Article  CAS  Google Scholar 

  15. Ficarra V, Galfano A, Mancini M, Martignoni G, Artibani W. TNM staging system for renal-cell carcinoma: current status and future perspectives. Lancet Oncol. 2007;8(6):554–8.

    Article  Google Scholar 

  16. Hansen TF, Spindler KL, Lorentzen KA, Olsen DA, Andersen RF, Lindebjerg J, et al. Quantitative analysis of vascular endothelial growth factor receptors 1 and 2 in colorectal cancer. Mol Med Rep. 2009;2(5):787–92.

    Article  CAS  Google Scholar 

  17. Vartanian RK, Weidner N. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason’s score, microvessel density, and epithelial cell proliferation. Lab Investig. 1995;73(6):844–50.

    CAS  PubMed  Google Scholar 

  18. Leal MF, Belangero PS, Cohen C, Figueiredo EA, Loyola LC, Pochini AC, et al. Identification of suitable reference genes for gene expression studies of shoulder instability. PLoS ONE. 2014;9(8):e105002.

    Article  Google Scholar 

  19. Kriegel AJ, Liang M. MicroRNA in situ hybridization for formalin fixed kidney tissues. J Vis Exp. 2013. doi:https://doi.org/10.3791/50785. 81.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Plummer PN, Freeman R, Taft RJ, Vider J, Sax M, Umer BA, et al. MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Res. 2013;73(1):341–52.

    Article  CAS  Google Scholar 

  21. Imam JS, Buddavarapu K, Lee-Chang JS, Ganapathy S, Camosy C, Chen Y, et al. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene. 2010;29(35):4971–9.

    Article  CAS  Google Scholar 

  22. Müller S, Nowak K. Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles. Biomed Res Int. 2014;2014:948408.

    Article  Google Scholar 

  23. Sharma SG, Aggarwal N, Gupta SD, Singh MK, Gupta R, Dinda AK. Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors. Int Urol Nephrol. 2011;43(1):125–9.

    Article  CAS  Google Scholar 

  24. Vecchione A, Belletti B, Lovat F, Volinia S, Chiappetta G, Giglio S, et al. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci U S A. 2013;110(24):9845–50.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

Special thanks to the faculty of the Department of Pathology, Zhongshan Hospital, Fudan University.

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Ultrasound, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, 200032, Shanghai, People’s Republic of China

    Hai-Xia Yuan & Wen-Ping Wang

  2. Department of Urology, Zhongshan Hospital, Fudan University, No.180 Fenglin Road, 200032, Shanghai, People’s Republic of China

    Jian-Ping Zhang, Wen-Tao Kong, Yu-Jun Liu, Zong-Ming Lin & Jian-Ming Guo

Authors
  1. Hai-Xia Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jian-Ping Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wen-Tao Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu-Jun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zong-Ming Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wen-Ping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jian-Ming Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yu-Jun Liu or Wen-Ping Wang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuan, HX., Zhang, JP., Kong, WT. et al. Elevated microRNA-185 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in clear cell renal cell carcinoma. Tumor Biol. 35, 12757–12763 (2014). https://doi.org/10.1007/s13277-014-2602-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2602-9

Keywords

Search

Navigation